Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China
Endocrinology, Diabetes & Metabolism · 2026-11 · 9 (6)
DOI: 10.1002/edm2.70368 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 06.11.2026. Verfasst von Qiang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Uric Acid, Creatinine. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Research Fund of Ningxia Clinical Research Institute, People's Hospital of Ningxia Hui Autonomous Region, the Natural Science Foundation of Ningxia.
Abstract (Originalsprache)
Objective
This study aimed to systematically compare the roles of both serum uric acid (SUA) and Serum uric acid to creatine ratio (SUACr) as indicators of metabolic syndrome (MetS) in general populations.
Methods
Information used here was gathered from a cross‐sectional investigation focusing on NHAR, about cardiovascular disease risk factors and prevalence. Dose–response relation between SUA, SUACr and MetS was evaluated using RCS model. Moreover, a logistic regression modelling was generated to evaluate the relation among SUA, SUACr and MetS within the total population.
Results
A total of 10,217 subjects aged 18 and over were enrolled. Both SUA and SUACr were significantly associated with MetS and individual corresponding diseases in this population. Adjusted odds ratios indicated a progressive increase in the risk of MetS and individual corresponding diseases across quartiles of SUA and SUACr, all with the lowest quartile as reference for both genders ( p for trend < 0.001). AUC of SUACr surpassed that for SUA in identifying MetS (0.61 vs. 0.59, p < 0.001). However, no statistical difference was observed between SUA and SUACr when stratified by gender. In men, the AUC of SUA and SUACr for MetS diagnosis were 0.61 and 0.62, respectively, while both SUA and SUACr had an AUC value of 0.62 in women.
Conclusions
SUA and SUACr could serve as valuable predictors for early prevention, diagnosis and treatment of MetS in routine clinical practice. Upon gender stratification, there was no discernible statistical difference between SUA and SUACr in identifying MetS presence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
- School of Public Health, Ningxia Medical University, Yinchuan, Ningxia Hui Autonomous Region, China.
- Ningxia Clinical Research Institute, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia Hui Autonomous Region, China.
ORCID-Profile: Chao Shi
Förderung
- Open Research Fund of Ningxia Clinical Research Institute, People's Hospital of Ningxia Hui Autonomous Region, the Natural Science Foundation of Ningxia
Zitieren
APA
Wang, Q., Wu, L., Ma, L., Cheng, Y., Liu, Y., Ma, J., Tong, H., & Shi, C. (2026). Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China. Endocrinology, Diabetes & Metabolism, 9(6). https://doi.org/10.1002/edm2.70368
Vancouver
Wang Q, Wu L, Ma L, Cheng Y, Liu Y, Ma J, et al. Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China. Endocrinology, Diabetes & Metabolism. 2026;9(6). doi:10.1002/edm2.70368
BibTeX
@article{Wang2026,
author = {Wang, Qiang and Wu, Lanqiqi and Ma, Ling and Cheng, Yin and Liu, Yining and Ma, Jinyu and Tong, Huitian and Shi, Chao},
title = {Comparison of Serum Uric Acid and Serum Uric Acid‐to‐Creatinine Ratio as Indicators of Metabolic Syndrome: A Cross‐Sectional Study in China},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {6},
doi = {10.1002/edm2.70368}
}
EUVIMED